Kathryn A. Peterson, MD, MSci

Journal Article

1. Pyne AL, Uchida AM, Hazel MW, Stubben CJ, Chang JW, Bailey DD, Gonsalves N, Allen-Brady K, Peterson KA, Pletneva MA (2024). Effect of benralizumab on histopathology and inflammatory signatures in a clinical cohort of eosinophilic esophagitis. Dis Esophagus. (Read full article)
2. Rothenberg ME, Dellon ES, Collins MH, Bredenoord AJ, Hirano I, Peterson KA, Brooks L, Caldwell JM, Fjllbrant H, Grindebacke H, Ho CN, Keith M, McCrae C, Sinibaldi D, White WI, Datto CJ, MESSINA Trial Investigators (2024). Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis. N Engl J Med, 390(24), 2252-2263. (Read full article)
3. Kim S, Morgenstern NB, Osonoi K, Aceves SS, Arva NC, Chehade M, Collins MH, Dellon ES, Falk GW, Furuta GT, Gonsalves NP, Gupta SK, Hirano I, Hiremath G, Katzka DA, Khoury P, Leung J, Pesek R, Peterson KA, Pletneva M, Spergel JM, Wechsler JB, Yang GY, Rothenberg ME, Shoda T (2024). Non-epithelial Gene Expression Correlates with Symptom Severity in Adults with Eosinophilic Esophagitis. J Allergy Clin Immunol Pract. (Read full article)
4. Sato H, Dellon ES, Aceves SS, Arva NC, Chehade M, Collins MH, Davis CM, Falk GW, Furuta GT, Gonsalves NP, Gupta SK, Hirano I, Hiremath G, Katzka DA, Khoury P, Leung J, Menard-Katcher P, Pesek R, Peterson KA, Pletneva MA, Spergel JM, Wechsler JB, Yang GY, Rothenberg ME, Shoda T (2024). Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis. J Allergy Clin Immunol. (Read full article)
5. Chehade M, Wright BL, Walsh S, Bailey DD, Muir AB, Klion AD, Collins MH, Davis CM, Furuta GT, Gupta S, Khoury P, Peterson KA, Jensen ET (2024). Challenging assumptions about the demographics of eosinophilic gastrointestinal diseases: A systematic review. J Allergy Clin Immunol Glob, 3(3), 100260. (Read full article)
6. Reddy CA, Allen-Brady K, Uchida AM, Peterson KA, Hoffman AM, Souza RF, Spechler SJ (2023). Achalasia is Strongly Associated With Eosinophilic Esophagitis and Other Allergic Disorders. Clin Gastroenterol Hepatol, 22(1), 34-41.e2. (Read full article)
7. Dellon ES, Peterson KA, Mitlyng BL, Iuga A, Bookhout CE, Cortright LM, Walker KB, Gee TS, McGee SJ, Cameron BA, Galanko JA, Woosley JT, Eluri S, Moist SE, Hirano I (2023). Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Gut, 72(10), 1828-1837. (Read full article)
8. Toy G, Colletier K, Hale G, Valentine J, Gawron AJ, Sossenheimer M, Peterson K, Aparicio R, Fang JC (2023). Incidence of retained biopsy specimens after esophagogastroduodenoscopy and colonoscopy. Endosc Int Open, 11(7), E653-E659. (Read full article)
9. Dellon ES, Peterson KA, Mitlyng BL, Iuga A, Bookhout CE, Cortright LM, Walker KB, Gee TS, McGee SJ, Cameron BA, Galanko JA, Woosley JT, Eluri S, Moist SE, Hirano I (2023). Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Gut, 72(10), 1828-1837. (Read full article)
10. Reddy CA, Allen-Brady K, Uchida AM, Peterson KA, Hoffman AM, Souza RF, Spechler SJ (2023). Achalasia is Strongly Associated with Eosinophilic Esophagitis and Other Allergic Disorders. Clin Gastroenterol Hepatol, 22(1), 34-41.e2. (Read full article)
11. Kliewer KL, Gonsalves N, Dellon ES, Katzka DA, Abonia JP, Aceves SS, Arva NC, Besse JA, Bonis PA, Caldwell JM, Capocelli KE, Chehade M, Cianferoni A, Collins MH, Falk GW, Gupta SK, Hirano I, Krischer JP, Leung J, Martin LJ, Menard-Katcher P, Mukkada VA, Peterson KA, Shoda T, Rudman Spergel AK, Spergel JM, Yang GY, Zhang X, Furuta GT, Rothenberg ME (2023). One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. Lancet Gastroenterol Hepatol. (Read full article)
12. Talley NJ, Peterson KA, Genta RM, Chang AT, Dellon ES, Sandborn WJ, 019 Study Team (2022). High discovery rate of duodenal and gastric eosinophilia in patients with unexplained moderate-severe abdominal symptoms: A prospective US multi-site study. Gastroenterology, 164(4), 680-683.e2. (Read full article)
13. Leiman DA, Kamal AN, Otaki F, Bredenoord AJ, Dellon ES, Falk GW, Fernandez-Becker NQ, Gonsalves N, Hirano I, Katzka DA, Peterson K, Yadlapati R, Kathpalia P (2022). Quality Indicators for the Diagnosis and Management of Eosinophilic Esophagitis. Am J Gastroenterol. (Read full article)
14. Chang JW, Kliewer K, Katzka DA, Peterson KA, Gonsalves N, Gupta SK, Furuta GT, Dellon ES (2022). Provider Beliefs, Practices, and Perceived Barriers to Dietary Elimination Therapy in Eosinophilic Esophagitis. Am J Gastroenterol, 117(12), 2071-2074. (Read full article)
15. Pyne AL, Hazel MW, Uchida AM, Qeadan F, Jordan KC, Holman A, Harward B, Gleich GJ, Peterson KA (2022). Oesophageal secretions reveal local food-specific antibody responses in eosinophilic oesophagitis. Aliment Pharmacol Ther, 56(9), 1328-1336. (Read full article)
16. Allen-Brady K, Colletier KJ, Woller S, Eliason K, Uchida AM, Ro G, Newman M, Peterson KA (2022). Eosinophilic Gastritis and Enteritis Are Increased in Families with Eosinophilic Esophagitis. Am J Gastroenterol, 118(2), 263-268. (Read full article)
17. Uchida AM, Ro G, Qiang L, Peterson KA, Round J, Dougan M, Dougan SK (2022). Human differentiated eosinophils release IL-13 in response to IL-33 stimulation. Front Immunol, 13, 946643. (Read full article)
18. Parbhu SK, Shah SC, Sossenheimer MJ, Fang JC, Peterson KA, Gawron AJ (2022). Index diagnoses of gastric intestinal metaplasia in the United States: patient characteristics, endoscopic findings, and clinical practice patterns at a large tertiary care center. Therap Adv Gastroenterol, 15, 17562848221117640. (Read full article)
19. Chang JW, Kliewer K, Katzka DA, Peterson KA, Gonsalves N, Gupta SK, Furuta GT, Dellon ES (2022). Provider beliefs, practices, and perceived barriers to dietary elimination therapy in eosinophilic esophagitis. Am J Gastroenterol, 117(12), 2071-2074. (Read full article)
20. Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-Katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, McGowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves SS (2022). A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. Gastroenterology. (Read full article)
21. Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-Katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, McGowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves SS (2022). A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. J Allergy Clin Immunol. (Read full article)
22. Peterson K, Clayton F, Qeadan F, Gorman D, Robson J, Allen-Brady K, Fang JC (2020). Esophageal Eosinophilia Is Common Among Relatives of Eosinophilic Esophagitis Patients. Clin Gastroenterol Hepatol, 20(5), e957-e963. (Read full article)
23. Qeadan F, Tingey B, Egbert J, Pezzolesi MG, Burge MR, Peterson KA, Honda T (2022). The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data. PLoS One, 17(4), e0266809. (Read full article)
24. Dellon ES, Gonsalves N, Abonia JP, Alexander JA, Arva NC, Atkins D, Attwood SE, Auth MKH, Bailey DD, Biederman L, Blanchard C, Bonis PA, Bose P, Bredenoord AJ, Chang JW, Chehade M, Collins MH, Di Lorenzo C, Dias JA, Dohil R, Dupont C, Falk GW, Ferreira CT, Fox AT, Genta RM, Greuter T, Gupta SK, Hirano I, Hiremath GS, Horsley-Silva JL, Ishihara S, Ishimura N, Jensen ET, Gutirrez-Junquera C, Katzka DA, Khoury P, Kinoshita Y, Kliewer KL, Koletzko S, Leung J, Liacouras CA, Lucendo AJ, Martin LJ, McGowan EC, Menard-Katcher C, Metz DC, Miller TL, Moawad FJ, Muir AB, Mukkada VA, Murch S, Nhu QM, Nomura I, Nurko S, Ohtsuka Y, Oliva S, Orel R, Papadopoulou A, Patel DA, Pesek RD, Peterson KA, Philpott H, Putnam PE, Richter JE, Rosen R, Ruffner MA, Safroneeva E, Schreiner P, Schoepfer A, Schroeder SR, Shah N, Souza RF, Spechler SJ, Spergel JM, Straumann A, Talley NJ, Thapar N, Vandenplas Y, Venkatesh RD, Vieira MC, von Arnim U, Walker MM, Wechsler JB, Wershil BK, Wright BL, Yamada Y, Yang GY, Zevit N, Rothenberg ME, Furuta GT, Aceves SS (2022). International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature. Clin Gastroenterol Hepatol. (Read full article)
25. Ma C, Bredenoord AJ, Dellon ES, Alexander JA, Biedermann L, Hogan M, Guizzetti L, Zou G, Katzka DA, Chehade M, Falk GW, Furuta GT, Gupta SK, Kagalwalla AF, Schoepfer AM, Miehlke S, Moawad FJ, Peterson K, Gonsalves NP, Straumann A, Wechsler JB, Rmillard J, Shackelton LM, Almonte HS, Feagan BG, Jairath V, Hirano I (2022). Reliability and responsiveness of endoscopic disease activity assessment in eosinophilic esophagitis. Gastrointest Endosc. (Read full article)
26. Rothenberg ME, Hottinger SKB, Gonsalves N, Furuta GT, Collins MH, Talley NJ, Peterson K, Menard-Katcher C, Smith M, Hirano I, Genta RM, Chehade M, Gupta SK, Spergel JM, Aceves SS, Dellon ES (2021). Impressions and aspirations from the FDA GREAT VI Workshop on Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis and Perspectives for Progress in the Field. J Allergy Clin Immunol. (Read full article)
27. Zimmermann N, Abonia JP, Dreskin SC, Akin C, Bolton S, Happel CS, Geller M, Larenas-Linnemann D, Nanda A, Peterson K, Wasan A, Wechsler J, Zhang S, Bernstein JA (2021). Developing a standardized approach for assessing mast cells and eosinophils on tissue biopsies: A Work Group Report of the AAAAI Allergic Skin Diseases Committee. J Allergy Clin Immunol. (Read full article)
28. Peterson K, Safroneeva E, Schoepfer A (2021). Emerging Therapies for Eosinophilic Gastrointestinal Diseases. J Allergy Clin Immunol Pract. (Read full article)
29. COREOS Collaborators, Ma C, Schoepfer AM, Dellon ES, Bredenoord AJ, Chehade M, Collins MH, Feagan BG, Furuta GT, Gupta SK, Hirano I, Jairath V, Katzka DA, Pai RK, Rothenberg ME, Straumann A, Aceves SS, Alexander JA, Arva NC, Atkins D, Biedermann L, Blanchard C, Cianferoni A, Ciriza de Los Rios C, Clayton F, Davis CM, de Bortoli N, Dias JA, Falk GW, Genta RM, Ghaffari G, Gonsalves N, Greuter T, Hopp R, Hsu Blatman KS, Jensen ET, Johnston D, Kogalwalla AF, Larsson HM, Leung J, Louis H, Masterson JC, Menard-Katcher C, Menard-Katcher PA, Moawad FJ, Muir AB, Mukkada VA, Penagini R, Pesek RD, Peterson K, Putnam PE, Ravelli A, Savarino EV, Schlog C, Schreiner P, Simon D, Smyrk TC, Spergel JM, Taft TH, Terrehorst I, Vanuytsel T, Venter C, Vieira MC, Vieth M, Vlieg-Boerstra B, von Arnim U, Walker MM, Wechsler JB, Woodland P, Woosley JT, Yang GY, Zevit N, Safroneeva EJ (2021). Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS) PMID: 34242635. Clin Immunol.
30. Dellon ES, Gonsalves N, Rothenberg ME, Hirano I, Chehade M, Peterson KA, Falk GW, Murray JA, Gehman LT, Chang AT, Singh B, Rasmussen HS, Genta RM (2021). Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial of Lirentelimab. Clin Gastroenterol Hepatol, 20(3), 535-545.e15. (Read full article)
31. Ravi A, Marietta EV, Alexander JA, Peterson K, Lavey C, Geno DM, Murray JA, Katzka DA (2020). Mucosal penetration and clearance of gluten and milk antigens in eosinophilic oesophagitis. Aliment Pharmacol Ther, 53(3), 410-417. (Read full article)
32. Dellon ES, Peterson KA, Murray JA, Falk GW, Gonsalves N, Chehade M, Genta RM, Leung J, Khoury P, Klion AD, Hazan S, Vaezi M, Bledsoe AC, Durrani SR, Wang C, Shaw C, Chang AT, Singh B, Kamboj AP, Rasmussen HS, Rothenberg ME, Hirano I (2020). Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis. N Engl J Med, 383(17), 1624-1634. (Read full article)
33. DeLay K, Pandolfino JE, Gyawali CP, Frye J, Kaizer A, Menard-Katcher P, Sloan JA, Gawron AJ, Peterson K, Carlson DA, Khan A, Keswani RN, Yadlapati R (2020). Esophageal Manometry Competency Program Improves Gastroenterology Fellow Performance in Motility Interpretation. Am J Gastroenterol, 115(9), 1453-1459. (Read full article)
34. Peterson K, Lin E, Saffari H, Qeadan F, Pyne A, Firszt R, Robson J, Gleich G (2020). Food-specific antibodies in oesophageal secretions: association with trigger foods in eosinophilic oesophagitis. Aliment Pharmacol Ther, 52(6), 997-1007. (Read full article)
35. Peterson KA, Gleich GJ, Limaye NS, Crispin H, Robson J, Fang J, Saffari H, Clayton F, Leiferman KM (2019). Eosinophil granule major basic protein 1 deposition in eosinophilic esophagitis correlates with symptoms independent of eosinophil counts. Dis Esophagus, 32(11). (Read full article)
36. Hirano I, Dellon ES, Hamilton JD, Collins MH, Peterson K, Chehade M, Schoepfer AM, Safroneeva E, Rothenberg ME, Falk GW, Assouline-Dayan Y, Zhao Q, Chen Z, Swanson BN, Pirozzi G, Mannent L, Graham NMH, Akinlade B, Stahl N, Yancopoulos GD, Radin A (2019). Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis. Gastroenterology. (Read full article)
37. Youngblood BA, Brock EC, Leung J, Falahati R, Bochner BS, Rasmussen HS, Peterson K, Bebbington C, Tomasevic N (2019). Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis. JCI Insight, 4(19). (Read full article)
38. McClain A, OGorman M, Barbagelata C, Patel R, Lowichik A, Peterson K, Guthery S, Robson J (2019). Adherence to Biopsy and Follow-Up Guidelines in a Population-Based Cohort of Children With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol, 18(11), 2620-2622. (Read full article)
39. Robson J, Korgenski K, Parsons K, McClain A, Barbagelata C, Allen-Brady K, Patel R, OGorman M, Peterson K, Guthery S (2019). Sensitivity and Specificity of Administrative Medical Coding for Pediatric Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr, 69(2), e49-e53. (Read full article)
40. Robson J, Laborda T, Fitzgerald S, Andersen J, Peterson K, OGorman M, Guthery S, Bennett-Murphy L (2019). Avoidant/Restrictive Food Intake Disorder in Diet-treated Children With Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr, 69(1), 57-60. (Read full article)
41. Siebermair J, Suksaranjit P, McGann CJ, Peterson KA, Kheirkhahan M, Baher AA, Damal K, Wakili R, Marrouche NF, Wilson BD (2019). Atrial fibrosis in non-atrial fibrillation individuals and prediction of atrial fibrillation by use of late gadolinium enhancement magnetic resonance imaging. J Cardiovasc Electrophysiol, 30(4), 550-556. (Read full article)
42. Robson J, OGorman M, McClain A, Mutyala K, Davis C, Barbagelata C, Wheeler J, Firszt R, Smith K, Patel R, Peterson K, Lowichik A, Guthery S (2018). Incidence and Prevalence of Pediatric Eosinophilic Esophagitis in Utah Based on a 5-Year Population-Based Study. Clin Gastroenterol Hepatol, 17(1), 107-114.e1. (Read full article)
43. Johnson J, Affolter K, Boynton K, Chen X, Valentine J, Peterson K (2017). CMV Disease in IBD: Comparison of Diagnostic Tests and Correlation with Disease Outcome. Inflamm Bowel Dis, 24(7), 1539-1546. (Read full article)
44. Laing P, Bress AP, Fang J, Peterson K, Adler DG, Gawron AJ (2017). Trends in diagnoses after implementation of the Chicago classification for esophageal motility disorders (V3.0) for high-resolution manometry studies. Dis Esophagus, 30(12), 1-6. (Read full article)
45. Martin L, Mullaney S, Peche W, Peterson K, Chan S, Morton R, Wan Y, Zhang C, Presson AP, Emery B, Aston K, Jenkins T, Carrell D, Hotaling J (2017). Population-based Semen Analysis Results and Fertility Among Patients With Inflammatory Bowel Disease: Results From Subfertility Health Assisted Reproduction and the Environment (SHARE) Study. Urology, 107, 114-119. (Read full article)
46. Frech TM, Fakoya L, Gawron AJ, Wong J, Scholand MB, Sawitzke A, Peterson K (2017). Oesophageal disease in systemic sclerosis: does heritability play a role? Clin Exp Rheumatol, 35 Suppl 106(4), 86-88. (Read full article)
47. Allred D, Frech TM, McComber C, Peterson K, Ortiz G, McNeill C, Broadbent L, Elorreaga N, Miller T, Scholand MB (2019). Chronic Multiorgan Rare Disease: The Role of the Nurse Practitioner as a Leader of the Healthcare Team. J Med Pract Manage, 32(6), 413-416. (Read full article)
48. Peterson K, Firszt R, Fang J, Wong J, Smith KR, Brady KA (2016). Risk of Autoimmunity in EoE and Families: A Population-Based Cohort Study. Am J Gastroenterol, 111(7), 926-32. (Read full article)
49. Padia R, Curtin K, Peterson K, Orlandi RR, Alt J (2016). Eosinophilic esophagitis strongly linked to chronic rhinosinusitis. Laryngoscope, 126(6), 1279-83. (Read full article)
50. Saffari H, Kennedy A, Peterson KA, Gleich GJ, Pease LF 3rd (2015). Non-invasive ultrasound to identify eosinophil granule proteins in eosinophilic esophagitis. Ultrasound Med Biol, 41(3), 884-9. (Read full article)
51. Peterson KA, Boynton KK (2013). Which patients with eosinophilic esophagitis (EoE) should receive elemental diets versus other therapies? Curr Gastroenterol Rep, 16(1), 364. (Read full article)
52. Faigel DO, Eisen GM, Baron TH, Dominitz JA, Goldstein JL, Hirota WK, Jacobson BC, Johanson JF, Leighton JA, Mallery JS, Peterson KA, Raddawi HM, Varg JJ 2nd, Waring JP, Fanelli RD, Wheeler-Harbough J, Standards of Practice Committee American Society for Gastrointestinal Endoscopy (2003). Tissue sampling and analysis. Gastrointest Endosc, 57(7), 811-6. (Read full article)
53. Faigel DO, Baron TH, Goldstein JL, Hirota WK, Jacobson BC, Johanson JF, Leighton JA, Mallery JS, Peterson KA, Waring JP, Fanelli RD, Wheeler-Harbaugh J, Standards Practice Committe American Society for Gastrointestinal Endoscopy (2002). Guidelines for the use of deep sedation and anesthesia for GI endoscopy. Gastrointest Endosc, 56(5), 613-7. (Read full article)

Review

1. Chang JW, Kliewer K, Haller E, Lynett A, Doerfler B, Katzka DA, Peterson KA, Dellon ES, Gonsalves N, Consortium of Eosinophilic Gastrointestinal Disease Researchers (2023). Development of a practical guide to implement and monitor diet therapy for eosinophilic esophagitis. [Review]. Clin Gastroenterol Hepatol. (Read full article)
2. Uchida AM, Ro G, Garber JJ, Peterson KA, Round JL (2022). Models and Tools for Investigating Eosinophilic Esophagitis at the Bench. [Review]. Front Immunol, 13, 943518. (Read full article)

Conference Proceedings

1. Ma C, Schoepfer AM, Safroneeva E, COREOS Collaborators, COREOS Collaborators (2021). Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus. Gastroenterology, United States, 161(3), 748-755. (Read full article)

Commentary

1. Ma C, Schoepfer AM, Safroneeva E, COREOS Collaborators (2021). A Summary of the Meetings of the Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS) International Multidisciplinary Consensus. Gastroenterology, 161(3), 778-784. (Read full article)

Editorial

1. Gupta SK, Falk GW, Aceves SS, Chehade M, Collins MH, Dellon ES, Gonsalves N, Hirano I, Mukkuda VA, Peterson KA, Spergel J, Yang GY, Furuta GT, Rothenberg ME, Consortium of Eosinophilic Gastrointestinal Disease Researchers CEGIR (2018). Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration. Gastroenterology, 156(4), 838-842. (Read full article)

Letter

1. Spechler SJ, Reddy CA, Allen-Brady K, Uchida AM, Peterson KA, Hoffman AM, Souza RF (2023). Reply. [Letter to the editor]. Clin Gastroenterol Hepatol. (Read full article)
2. May Maestas M, Perry KD, Smith K, Firszt R, Allen-Brady K, Robson J, Joy E, Peterson K (2019). Food impactions in Eosinophilic esophagitis and acute exposures to fine particulate pollution. [Letter to the editor]. Allergy, 74(12), 2529-2530. (Read full article)

Other

1. Chen JW, Vela MF, Peterson KA, Carlson DA (2023). AGA Clinical Practice Update on the Diagnosis and Management of Extraesophageal Gastroesophageal Reflux Disease: Expert Review. Clin Gastroenterol Hepatol (21(6), pp. 1414-1421.e3). United States. (Read full article)
2. Aceves SS, Alexander JA, Baron TH, Bredenoord AJ, Day L, Dellon ES, Falk GW, Furuta GT, Gonsalves N, Hirano I, Konda VJA, Lucendo AJ, Moawad F, Peterson KA, Putnam PE, Richter J, Schoepfer AM, Straumann A, McBride DL, Sharma P, Katzka DA (2022). Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference. Gastrointest Endosc. United States. (Read full article)
3. Hirano I, Collins MH, King E, Sun Q, Chehade M, Abonia JP, Bonis PA, Capocelli KE, Dellon ES, Falk GW, Gonsalves N, Gupta SK, Leung J, Katzka D, Menard-Katcher P, Khoury P, Klion A, Mukkada VA, Peterson K, Shoda T, Rudman-Spergel AK, Spergel JA, Yang GY, Rothenberg ME, Aceves SS, Furuta GT, CEGIR investigators (2021). Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort. Am J Gastroenterol (117(3), pp. 413-423). United States. (Read full article)
4. COREOS Collaborators, Ma C, Schoepfer AM, Dellon ES, Bredenoord AJ, Chehade M, Collins MH, Feagan BG, Furuta GT, Gupta SK, Hirano I, Jairath V, Katzka DA, Pai RK, Rothenberg ME, Straumann A, Aceves SS, Alexander JA, Arva NC, Atkins D, Biedermann L, Blanchard C, Cianferoni A, Ciriza de Los Rios C, Clayton F, Davis CM, de Bortoli N, Dias JA, Falk GW, Genta RM, Ghaffari G, Gonsalves N, Greuter T, Hopp R, Hsu Blatman KS, Jensen ET, Johnston D, Kagalwalla AF, Larsson HM, Leung J, Louis H, Masterson JC, Menard-Katcher C, Menard-Katcher PA, Moawad FJ, Muir AB, Mukkada VA, Penagini R, Pesek RD, Peterson K, Putnam PE, Ravelli A, Savarino EV, Schlag C, Schreiner P, Simon D, Smyrk TC, Spergel JM, Taft TH, Terreehorst I, Vanuytsel T, Venter C, Vieira MC, Vieth M, Vlieg-Boerstra B, von Arnim U, Walker MM, Wechsler JB, Woodland P, Woosley JT, Yang GY, Zevit N, Safroneeva E (2021). Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS). J Allergy Clin Immunol (149(2), pp. 659-670). United States. (Read full article)
5. Qeadan F, Chehade M, Tingey B, Egbert J, Dellon ES, Peterson KA (2021). Patients with eosinophilic gastrointestinal disorders have lower in-hospital mortality rates related to COVID-19. J Allergy Clin Immunol Pract (9(12), pp. 4473-4476.e4). United States. (Read full article)
6. Saffari H, Peterson KA, Leiferman KM, Stabin MG, Krstyen JJ, Clayton FC, Pease LF 3rd, Yap JT, Hoffman JM, Gleich GJ (2019). Oral Administration of 99mTechnetium-Labeled Heparin in Eosinophilic Esophagitis. Mayo Clin Proc (95(3), pp. 449-458). England. (Read full article)

Patent

1. Pease LF, Saffari H, Gleich GJ, Leiferman KM, Peterson KA, Condie RM (2017). Methods for diagnosing and monitoring eosinophilic esophagitis. U.S. Patent No. 10,376,602. Washington, D.C.:U.S. Patent and Trademark Office.
2. Pease LF, Saffari H, Gleich GJ, Leiferman KM, Peterson KA, Condie RM (2013). Methods for diagnosing and monitoring eosinophilic esophagitis. U.S. Patent No. 9,789,212. Washington, D.C.:U.S. Patent and Trademark Office.

• Children and Adults with Eosinophilic Esophagitis (EoE), Gastritis (EG) and Colitis (EC)
• Tezepelumab: A Study Drug for Patients with Eosinophilic Esophagitis (EoE)
• Testing the Study Drug Barzolvolimab (CDX-0159) in Adults with Active Eosinophilic Esophagitis
• Testing Dupilumab in Adults with Eosinophilic Gastritis with or without Eosinophilic Duodenitis